Sinopharm Group Co Stock Performance

SHTDF Stock  USD 2.70  0.35  14.89%   
Sinopharm Group has a performance score of 4 on a scale of 0 to 100. The entity has a beta of -0.0256, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sinopharm Group are expected to decrease at a much lower rate. During the bear market, Sinopharm Group is likely to outperform the market. Sinopharm Group right now has a risk of 2.18%. Please validate Sinopharm Group jensen alpha, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Sinopharm Group will be following its existing price patterns.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sinopharm Group Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Sinopharm Group may actually be approaching a critical reversion point that can send shares even higher in April 2026. ...more
Begin Period Cash Flow50.2 B
Total Cashflows From Investing Activities-1.3 B
Free Cash Flow9.3 B
  

Sinopharm Group Relative Risk vs. Return Landscape

If you would invest  253.00  in Sinopharm Group Co on December 1, 2025 and sell it today you would earn a total of  17.00  from holding Sinopharm Group Co or generate 6.72% return on investment over 90 days. Sinopharm Group Co is currently producing 0.1268% returns and takes up 2.1787% volatility of returns over 90 trading days. Put another way, 19% of traded pink sheets are less volatile than Sinopharm, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Sinopharm Group is expected to generate 2.9 times more return on investment than the market. However, the company is 2.9 times more volatile than its market benchmark. It trades about 0.06 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

Sinopharm Group Target Price Odds to finish over Current Price

The tendency of Sinopharm Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.70 90 days 2.70 
roughly 2.81
Based on a normal probability distribution, the odds of Sinopharm Group to move above the current price in 90 days from now is roughly 2.81 (This Sinopharm Group Co probability density function shows the probability of Sinopharm Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Sinopharm Group Co has a beta of -0.0256. This usually implies as returns on the benchmark increase, returns on holding Sinopharm Group are expected to decrease at a much lower rate. During a bear market, however, Sinopharm Group Co is likely to outperform the market. Additionally Sinopharm Group Co has an alpha of 0.1112, implying that it can generate a 0.11 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Sinopharm Group Price Density   
       Price  

Predictive Modules for Sinopharm Group

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sinopharm Group. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sinopharm Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.522.704.88
Details
Intrinsic
Valuation
LowRealHigh
0.412.594.77
Details
Naive
Forecast
LowNextHigh
0.612.794.97
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.702.702.70
Details

Sinopharm Group Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sinopharm Group is not an exception. The market had few large corrections towards the Sinopharm Group's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sinopharm Group Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sinopharm Group within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.11
β
Beta against Dow Jones-0.03
σ
Overall volatility
0.11
Ir
Information ratio 0.01

Sinopharm Group Fundamentals Growth

Sinopharm Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Sinopharm Group, and Sinopharm Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sinopharm Pink Sheet performance.

About Sinopharm Group Performance

By analyzing Sinopharm Group's fundamental ratios, stakeholders can gain valuable insights into Sinopharm Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sinopharm Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sinopharm Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm Group is traded on OTC Exchange in the United States.

Things to note about Sinopharm Group performance evaluation

Checking the ongoing alerts about Sinopharm Group for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Sinopharm Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating Sinopharm Group's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Sinopharm Group's pink sheet performance include:
  • Analyzing Sinopharm Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sinopharm Group's stock is overvalued or undervalued compared to its peers.
  • Examining Sinopharm Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Sinopharm Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sinopharm Group's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Sinopharm Group's pink sheet. These opinions can provide insight into Sinopharm Group's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Sinopharm Group's pink sheet performance is not an exact science, and many factors can impact Sinopharm Group's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Sinopharm Pink Sheet analysis

When running Sinopharm Group's price analysis, check to measure Sinopharm Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinopharm Group is operating at the current time. Most of Sinopharm Group's value examination focuses on studying past and present price action to predict the probability of Sinopharm Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinopharm Group's price. Additionally, you may evaluate how the addition of Sinopharm Group to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins